The Coalition for Epidemic Preparedness Innovations (CEPI) today announced that Afrigen Biologics aims to develop the first-ever mRNA-based vaccine against Rift Valley fever, supported by a new $6.2 million grant. Confirmed on January 20, 2025, the... READ →
Vax-Before-Travel
/ January 20th, 2025Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.